286 related articles for article (PubMed ID: 12605722)
1. Final report of the Conference on the eradicability of Onchocerciasis.
Dadzie Y; Neira M; Hopkins D
Filaria J; 2003 Feb; 2(1):2. PubMed ID: 12605722
[TBL] [Abstract][Full Text] [Related]
2. The Onchocerciasis Elimination Program for the Americas (OEPA).
Sauerbrey M
Ann Trop Med Parasitol; 2008 Sep; 102 Suppl 1():25-9. PubMed ID: 18718151
[TBL] [Abstract][Full Text] [Related]
3. Assessment and monitoring of onchocerciasis in Latin America.
Rodríguez-Pérez MA; Unnasch TR; Real-Najarro O
Adv Parasitol; 2011; 77():175-226. PubMed ID: 22137585
[TBL] [Abstract][Full Text] [Related]
4. Is onchocerciasis elimination in Africa feasible by 2025: a perspective based on lessons learnt from the African control programmes.
Dadzie Y; Amazigo UV; Boatin BA; Sékétéli A
Infect Dis Poverty; 2018 Jul; 7(1):63. PubMed ID: 29966535
[TBL] [Abstract][Full Text] [Related]
5. Elimination of transmission of onchocerciasis (river blindness) with long-term ivermectin mass drug administration with or without vector control in sub-Saharan Africa: a systematic review and meta-analysis.
Mutono N; Basáñez MG; James A; Stolk WA; Makori A; Kimani TN; Hollingsworth TD; Vasconcelos A; Dixon MA; de Vlas SJ; Thumbi SM
Lancet Glob Health; 2024 May; 12(5):e771-e782. PubMed ID: 38484745
[TBL] [Abstract][Full Text] [Related]
6. The Mectizan Donation Program (MDP).
Thylefors B
Ann Trop Med Parasitol; 2008 Sep; 102 Suppl 1():39-44. PubMed ID: 18718154
[TBL] [Abstract][Full Text] [Related]
7. Hypo-endemic onchocerciasis hotspots: defining areas of high risk through micro-mapping and environmental delineation.
Kelly-Hope LA; Unnasch TR; Stanton MC; Molyneux DH
Infect Dis Poverty; 2015; 4():36. PubMed ID: 26279835
[TBL] [Abstract][Full Text] [Related]
8. Onchocerciasis and other eye problems in developing countries: a challenge for optometrists.
Berger IB; Nnadozie J
J Am Optom Assoc; 1993 Oct; 64(10):699-702. PubMed ID: 8245390
[TBL] [Abstract][Full Text] [Related]
9. The positive influence the Onchocerciasis Elimination Program for the Americas has had on Africa programs.
Richards FO; Nwoke BEB; Zarroug I; Tukahebwa E; Negussu N; Higazi TB; Oguttu D; Tadesse Z; Miri E; Aziz N; Habomugisha P; Katabarwa M
Infect Dis Poverty; 2019 Jul; 8(1):52. PubMed ID: 31303175
[TBL] [Abstract][Full Text] [Related]
10. The geographic distribution of onchocerciasis in the 20 participating countries of the African Programme for Onchocerciasis Control: (1) priority areas for ivermectin treatment.
Noma M; Zouré HG; Tekle AH; Enyong PA; Nwoke BE; Remme JH
Parasit Vectors; 2014 Jul; 7():325. PubMed ID: 25053266
[TBL] [Abstract][Full Text] [Related]
11. Towards the elimination of onchocerciasis.
Thylefors B; Alleman M
Ann Trop Med Parasitol; 2006 Dec; 100(8):733-46. PubMed ID: 17227651
[TBL] [Abstract][Full Text] [Related]
12. Progress toward elimination of onchocerciasis in the Americas.
Sauerbrey M; Rakers LJ; Richards FO
Int Health; 2018 Mar; 10(suppl_1):i71-i78. PubMed ID: 29471334
[TBL] [Abstract][Full Text] [Related]
13. Impact of combined large-scale ivermectin distribution and vector control on transmission of Onchocerca volvulus in the Niger basin, Guinea.
Guillet P; Sékétéli A; Alley ES; Agoua H; Boatin BA; Bissan Y; Akpoboua LK; Quillévéré D; Samba EM
Bull World Health Organ; 1995; 73(2):199-205. PubMed ID: 7743591
[TBL] [Abstract][Full Text] [Related]
14. Impact of ivermectin on onchocerciasis transmission: assessing the empirical evidence that repeated ivermectin mass treatments may lead to elimination/eradication in West-Africa.
Borsboom GJ; Boatin BA; Nagelkerke NJ; Agoua H; Akpoboua KL; Alley EW; Bissan Y; Renz A; Yameogo L; Remme JH; Habbema JD
Filaria J; 2003 Mar; 2(1):8. PubMed ID: 12769825
[TBL] [Abstract][Full Text] [Related]
15. Elimination of human onchocerciasis: history of progress and current feasibility using ivermectin (Mectizan(®)) monotherapy.
Cupp EW; Sauerbrey M; Richards F
Acta Trop; 2011 Sep; 120 Suppl 1():S100-8. PubMed ID: 20801094
[TBL] [Abstract][Full Text] [Related]
16. Ongoing Transmission of Onchocerca volvulus after 25 Years of Annual Ivermectin Mass Treatments in the Vina du Nord River Valley, in North Cameroon.
Eisenbarth A; Achukwi MD; Renz A
PLoS Negl Trop Dis; 2016 Feb; 10(2):e0004392. PubMed ID: 26926855
[TBL] [Abstract][Full Text] [Related]
17. Elimination of onchocerciasis in Africa by 2025: the need for a broad perspective.
Cupp E; Sauerbrey M; Cama V; Eberhard M; Lammie PJ; Unnasch TR
Infect Dis Poverty; 2019 Jul; 8(1):50. PubMed ID: 31303176
[TBL] [Abstract][Full Text] [Related]
18. Reaching the last mile: main challenges relating to and recommendations to accelerate onchocerciasis elimination in Africa.
Gebrezgabiher G; Mekonnen Z; Yewhalaw D; Hailu A
Infect Dis Poverty; 2019 Jul; 8(1):60. PubMed ID: 31269966
[TBL] [Abstract][Full Text] [Related]
19. The Onchocerciasis Elimination Program for the Americas: a history of partnership.
Blanks J; Richards F; Beltrán F; Collins R; Alvarez E; Zea Flores G; Bauler B; Cedillos R; Heisler M; Brandling-Bennett D; Baldwin W; Bayona M; Klein R; Jacox M
Rev Panam Salud Publica; 1998 Jun; 3(6):367-74. PubMed ID: 9734217
[TBL] [Abstract][Full Text] [Related]
20. Control of onchocerciasis.
Boatin BA; Richards FO
Adv Parasitol; 2006; 61():349-94. PubMed ID: 16735169
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
